Clinicians can pinpoint patients who are at a high risk of developing cardiovascular disease (CVD) with the use of the innovative AI-powered cardiovascular risk assessment tool called Viz™ Cardio. According to the World Health Organization, cardiovascular disease (CVD) caused 17.9 million deaths in 2019. Viz™ Cardio creates a unique risk assessment for each patient based on a range of data elements, including patient demographics, medical history, and test findings. Then, based on this score, clinicians can decide whether to start preventative treatment or refer patients for more testing.
Key Features
Viz™ Cardio evaluates a wide range of variables to provide a thorough risk assessment. It examines test findings and lifestyle variables in addition to more conventional risk factors including demographics and medical history. This multilayered strategy offers a more comprehensive and subtle knowledge of a person’s risk profile.
Compared to conventional approaches, which may rely on a constrained set of criteria, Viz™ Cardio may provide a far more precise and customized risk assessment by including a wider range of data. As a result, professionals may provide their patients with better advice and judgments, which will eventually improve the prevention and treatment of cardiovascular diseases.
Viz™ Cardio stands out from the competition by being incredibly user-friendly. It is available to physicians of all levels of expertise because it is a web-based tool. Viz™ Cardio quickly creates a risk score once doctors input the patient's pertinent data, streamlining the risk assessment procedure.
Due to its user-friendly layout, cardiovascular risk assessment can be effectively incorporated into the practice of time-constrained healthcare professionals without the need for in-depth training or knowledge of complicated algorithms.
The AI-powered aspect of Viz™ Cardio is revolutionary. Since it incorporates artificial intelligence, it can continually learn from new data and improve the accuracy of its risk assessment over time.
This dynamic adaptation is especially beneficial since it makes sure that risk assessments are current and reflect the most recent developments in clinical understanding and medical research. Viz™ Cardio improves its predicted accuracy by becoming better at seeing small patterns and correlations as it gathers more data and learns from various patient profiles.
Benefits
Viz™ Cardio improves patient care significantly by assisting doctors in identifying people at high risk of cardiovascular disease (CVD). This enhanced risk assessment tool enables healthcare practitioners to give individualized preventive treatment solutions to patients at risk, such as lifestyle changes, medication regimes, and regular monitoring.
Clinicians could possibly avoid CVD episodes and lower the possibility of serious consequences or even death by proactively treating risk factors. The capacity to act early and effectively in high-risk patients leads to better overall patient outcomes, a greater quality of life for people, and a decrease in the CVD load on healthcare systems.
Viz™ Cardio helps the healthcare industry save money in a big way. The cost of treating CVD is high since it necessitates several medical procedures, hospital stays, and continuous care. Viz™ Cardio helps lessen the long-term economic effect of the disease by reducing CVD episodes through early detection and tailored therapies.
For both healthcare providers and patients, fewer hospital stays, operations, and prolonged therapies result in considerable savings. The financial element of healthcare systems gains from this decrease in prices, but it also improves resource allocation and accessibility to medical treatments for a larger population.
The clinical workflow is streamlined with Viz™ Cardio, increasing healthcare practitioners' productivity. Clinicians can arrive at prompt and informed judgments without the time-consuming process of risk assessment due to the tool’s capacity to generate a thorough risk score in a matter of seconds.
In addition to accelerating the clinical procedure, this also effectively uses the time that physicians are allotted, allowing them to concentrate on patient care and decision-making rather than routine administrative activities.
In essence, Viz™ Cardio is a driver of cost-effectiveness and workflow efficiency in cardiovascular risk management in addition to being a catalyst for accurate and timely treatment. Its effects are felt by patients, doctors, and healthcare organizations, signaling the beginning of a new phase in the fight against cardiovascular diseases.